We are live on ! Find out more
LSBPW

LakeShore Biopharma Warrants
LSBPW

Delisted

LSBPW was delisted on the 19th of September, 2025.

Back to rankings

18 hedge funds and large institutions have $196K invested in LakeShore Biopharma Warrants in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 18 → 18 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0.03% less ownership

Funds ownership: 2.18% → 2.15% (-0.03%)

49% less capital invested

Capital invested by funds: $381K → $196K (-$185K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
18
Holders Change
–
Holders Change %
0%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
1
Calls
$20K
Puts
–
Net Calls
+$20K
Net Calls Change
-$20K

Top Buyers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
+$6.54K

Top Sellers

Rank Fund Capital Flow
1
OCM
Ovata Capital Management
Hong Kong
-$14.8K
2
CS
Clear Street
New York
-$33
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
1
LMR Partners
United Kingdom
$43.4K – – –
AC
2
Athos Capital
Hong Kong
$32K – – –
VAM
3
Valliance Asset Management
Hong Kong
$30.9K – – –
Jane Street
4
Jane Street
New York
$20.5K – – –
FC
5
Finepoint Capital
Massachusetts
$20.2K – – –
BCL
6
Bracebridge Capital LLC
Massachusetts
$9.57K – – –
Calamos Advisors
7
Calamos Advisors
Illinois
$6.03K – – –
WA
8
Whitebox Advisors
Minnesota
$5.15K – – –
QGA
9
Q Global Advisors
Texas
$5K – – –
TSS
10
Two Sigma Securities
New York
$4.41K +$6.54K +107,006 New
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$4.13K – – –
SCM
12
Saba Capital Management
New York
$4.01K – – –
Walleye Capital
13
Walleye Capital
New York
$3.92K – – –
CF
14
Cantor Fitzgerald
New York
$3.17K – – –
CS
15
Clear Street
New York
$1.96K -$33 -544 -1%
SIA
16
SkyView Investment Advisors
New Jersey
$1K – – –
AA
17
Ancora Advisors
Ohio
$208 – – –
HIM
18
HGC Investment Management
Ontario, Canada
$206 – – –
OCM
19
Ovata Capital Management
Hong Kong
– -$14.8K -150,000 Closed

LSBPW Hedge Fund Activity: Q1 2025 in Review

18 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in LakeShore Biopharma Warrants (LSBPW) for Q1 2025, worth a combined $196K — down 49% from $381K a quarter earlier.

Fund positioning in LSBPW was balanced in Q1 2025: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Two Sigma Securities, opening a new position worth an estimated $6.54K. The largest seller was Ovata Capital Management, exiting entirely with an estimated $14.8K sold.

  • 18 institutional investors held LakeShore Biopharma Warrants (LSBPW) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $196K of LakeShore Biopharma Warrants stock for Q1 2025, down 49% quarter-over-quarter.
  • 1 fund opened new LakeShore Biopharma Warrants positions in Q1 2025 and 1 closed out, a net change of 0 holders.
  • The largest LakeShore Biopharma Warrants buyer in Q1 2025 was Two Sigma Securities, an estimated $6.54K added.
  • The largest LakeShore Biopharma Warrants seller in Q1 2025 was Ovata Capital Management, an estimated $14.8K sold.

Based on aggregated 13F filings for Q1 2025.